SCHEMBL1164447

SCHEMBL1164447

CC1CCCC(C)CCC(C(C)C)CCC(C)CCC1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.34
TRPM8 Q7Z2W7 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350756 1.00 TRPA1 (0.34) TRPA1TRPM8
SCHEMBL332633 1.00 TRPA1 (0.34) TRPA1TRPM8
SCHEMBL7979 0.91 TRPA1 (0.39) TRPA1TRPM8
SCHEMBL1760669 0.91 TRPA1 (0.39) TRPA1TRPM8
SCHEMBL452781 0.91 TRPA1 (0.39) TRPA1TRPM8
Hydrochloric Acid SCHEMBL6863594 0.88 TRPA1 (0.37) TRPA1TRPM8
Ammonia Solution, Strong SCHEMBL5944185 0.88 TRPA1 (0.37) TRPA1TRPM8
Charcoal, Activated SCHEMBL4530459 0.88 TRPA1 (0.37) TRPA1TRPM8
Water SCHEMBL2851760 0.88 TRPA1 (0.37) TRPA1TRPM8
SCHEMBL38654752 0.88 TRPA1 (0.37) TRPA1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124172-A1 Use of cembrane-type diterpene compounds in the preparation of medicament for preventing or treating inflammasome mediated inflammatory disorders CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2026-05-07 US claimed
CN-120084936-A Method and system for predicting flavor components of heated cigarette tobacco shreds based on combined drying 浙江中烟工业有限责任公司 2025-06-03 CN claimed
CN-120058519-A Anti-inflammatory diterpenoid compounds, preparation method and application thereof 宁波大学 2025-05-30 CN claimed
CN-119161320-B Enantioselective alkane type 2-norditerpenoid lactone compound, and preparation method and application thereof 深圳市第二人民医院(深圳市转化医学研究院) 2025-05-16 CN claimed
CN-119867349-A Combined drying method and system for heated cigarette tobacco shreds based on fragrance component control 浙江中烟工业有限责任公司 2025-04-25 CN claimed
CN-117105896-B Enantioselective alkane type diterpenoid lactone compound, and preparation method and application thereof 深圳市第二人民医院(深圳市转化医学研究院) 2025-04-22 CN claimed
CN-119769772-A Tobacco shred combined drying method and system for heating cigarette production line 浙江中烟工业有限责任公司 2025-04-08 CN claimed
CN-119679101-A Method for preparing dried beef by synergistic fermentation of mixed microbial starter and spice 内蒙古农业大学 2025-03-25 CN claimed
CN-119613325-A High-solubility TEMPO quaternary ammonium salt based on active chlorine compound, preparation method thereof and application thereof in flow battery 北京慧储科技有限公司 2025-03-14 CN claimed
CN-119161320-A Enantioselective alkane type 2-norditerpenoid lactone compound, and preparation method and application thereof 深圳市第二人民医院(深圳市转化医学研究院) 2024-12-20 CN claimed
CN-113402528-A Cedarane type macrocyclic diterpenoid compound, preparation method, pharmaceutical composition and application 中国医学科学院药物研究所 2021-09-17 CN claimed
CN-112876361-A Cedarane diterpenoid compound and preparation method and application thereof 宁波大学 2021-06-01 CN claimed
CN-108640890-B Method for separating and purifying cembrane type macrocyclic diterpenoid compounds in frankincense 山东省分析测试中心 2020-05-05 CN claimed
CN-110583688-A Synergistic pesticide containing glyphosate 广西拜科生物科技有限公司 2019-12-20 CN claimed
US-9273342-B2 Methods and systems for evaluating and predicting the reactivity of monooxygenase enzymes UNIVERSITY OF ROCHESTER (US) 2016-03-01 US claimed
US-20140038850-A1 METHODS AND SYSTEMS FOR EVALUATING AND PREDICTING THE REACTIVITY OF MONOOXYGENASE ENZYMES UNIVERSITY OF ROCHESTER (US) 2014-02-06 US claimed
WO-2012109586-A2 METHODS AND SYSTEMS FOR EVALUATING AND PREDICTING THE REACTIVITY OF MONOOXYGENASE ENZYMES UNIVERSITY OF ROCHESTER (US) 2012-08-16 WO claimed
EP-0258082-B1 ANTI-SOLID TUMOR AGENTS MITSUBISHI KASEI CORPORATION (JP) 1993-03-10 EP claimed
EP-0448128-B1 CEMBRANE-TYPE DITERPENE COMPOUNDS FOR USE IN THE PRODUCTION OF COMPOSITIONS CONTAINING HISTAMINE RELEASE INHIBITORS MITSUBISHI KASEI CORPORATION (JP) 1993-03-03 EP claimed
EP-0271387-B1 CEMBRANE-TYPE DITERPENE COMPOUNDS FOR USE IN THE PRODUCTION OF COMPOSITIONS CONTAINING LYSOSOME LIBERATION INHIBITORS MITSUBISHI KASEI CORPORATION (JP) 1992-09-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124172-A1 Use of cembrane-type diterpene compounds in the preparation of medicament for preventing or treating inflammasome mediated inflammatory disorders CASP1, CASP14, PYCARD TRPA1 31/4885TRPM8 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.